Abbott Laboratories (ABT) at a glance
Abbott Laboratories (ABT) is a large-cap Healthcare company. It trades at $103.57, with a P/E of 36.5, a 11.6% profit margin and revenue growth of 13%. It pays a 2.2% dividend yield. Vestovix scores it 48/100 overall. Its strongest dimension is Safety (70/100) and its weakest is Growth (33/100). It is a relatively defensive holding with below-market volatility.
- Price
- $103.57
- Market cap
- $194.98B
- P/E ratio
- 36.5
- Dividend yield
- 2.16%
- Beta
- 0.58
- 52-week range
- $81.97 to $137.49
Value
43
Growth
33
Income
54
Safety
70
Momentum
41
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield
TMO54
Thermo Fisher Scientific Inc.
$609.82-1.39%
0.38% yield